medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2026; 24 (2)

Efficacy of corticosteroid infiltration in cutaneous sarcoidosis: a case report

Vidal BJ, Hernández CD, Pichardo VL, Nanita EF, Cochón AM
Full text How to cite this article

Language: Spanish
References: 5
Page: 302-305
PDF size: 281.99 Kb.


Key words:

cutaneous sarcoidosis, intralesional corticosteroids, sarcoid granuloma.

ABSTRACT

Sarcoidosis is a multisystem disorder of unknown etiology characterized histopathologically by noncaseating granulomas. While it predominantly affects young adults, its clinical expression in the skin is highly polymorphic, manifesting as macules, papules, plaques, subcutaneous nodules, lupus pernio, or infiltrative scars. Current therapeutic strategies prioritize corticosteroids; specifically, intralesional triamcinolone acetonide has proven effective in modulating inflammation and achieving lesion resolution.
We report a 42-year-old female with cutaneous sarcoidosis localized to the nasal region. The patient was treated with intralesional triamcinolone acetonide (10 mg/mL), resulting in a favorable clinical response and significant flattening of the lesions.
The diagnostic complexity of cutaneous sarcoidosis lies in its “great imitator” nature. A thorough clinical evaluation supported by histopathological confirmation is essential to identify sarcoid granulomas and differentiate them from other dermatological conditions.
The management of cutaneous sarcoidosis necessitates a comprehensive approach, including multidisciplinary screening to rule out systemic involvement. Intralesional corticosteroid injections remain a safe and effective first-line therapy for localized disease, significantly improving both clinical outcomes and the patient’s quality of life.


REFERENCES

  1. Fortuño Y, Gallego I, Marcoval J. Sarcoidosis cutánea. ActasDermosifiliográficas. 2004;95(3):137–53.

  2. Abu-Hilal M, Krotva J, Chichierchio L, Obeidat N, MadanatM. Dermatologic aspects and cutaneous manifestations ofsarcoidosis. Giornale Italiano di Dermatologia e Venereologia.2010;145(6):733–45.

  3. Koneti J, Cherukuri SP, Gadde S, Kalluru R, Chikatimalla R,Dasaradhan T. Sarcoidosis and its dermatological manifestations:a narrative review. Cureus. 2022;14(8):e28956

  4. Jadotte YT, Abdel Hay R, Salphale P, Mocellin S, Kumar S, NiaziA, Pilati P. Interventions for cutaneous sarcoidosis. CochraneDatabase of Systematic Reviews. 2018;(8):CD010817.

  5. Ramírez Huaranga MA, Ramos Rodríguez CC, de la RochaVedia IV, García Arpa M, Murillo Lázaro C, Bellón Guardia M.Sarcoidosis cutánea: el preámbulo de una enfermedad sistémicapaucisintomática. Reumatología Clínica. 2015;11(6):395–7.




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2026;24